These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 11837497

  • 1. Early manifestations of Prader-Willi syndrome: influence of growth hormone.
    Eiholzer U, Schlumpf M, Nordmann Y, l'Allemand D.
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1441-4. PubMed ID: 11837497
    [Abstract] [Full Text] [Related]

  • 2. Prader-Willi syndrome: how does growth hormone affect body composition and physical function?
    Carrel AL, Allen DB.
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1445-51. PubMed ID: 11837498
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [Abstract] [Full Text] [Related]

  • 4. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE, Carrel AL, Whitman BY, Allen DB.
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC, Lindberg A.
    Horm Res; 2008 Jul; 70(3):182-7. PubMed ID: 18663319
    [Abstract] [Full Text] [Related]

  • 6. Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome.
    Festen DA, Wevers M, Lindgren AC, Böhm B, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):919-25. PubMed ID: 18031326
    [Abstract] [Full Text] [Related]

  • 7. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M, Deal C, Van Vliet G.
    J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome.
    Carrel AL, Moerchen V, Myers SE, Bekx MT, Whitman BY, Allen DB.
    J Pediatr; 2004 Dec; 145(6):744-9. PubMed ID: 15580194
    [Abstract] [Full Text] [Related]

  • 9. Analysis of NREM sleep in children with Prader-Willi syndrome and the effect of growth hormone treatment.
    Verrillo E, Bruni O, Franco P, Ferri R, Thiriez G, Pavone M, Petrone A, Paglietti MG, Crinò A, Cutrera R.
    Sleep Med; 2009 Jun; 10(6):646-50. PubMed ID: 19027358
    [Abstract] [Full Text] [Related]

  • 10. Association between foot growth and musculoskeletal loading in children with Prader-Willi syndrome before and during growth hormone treatment.
    Eiholzer U, Meinhardt U, Gallo C, Schlumpf M, Rousson V, l'Allemand D.
    J Pediatr; 2009 Feb; 154(2):225-9. PubMed ID: 18822426
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome.
    Eiholzer U, L'allemand D, Schlumpf M, Rousson V, Gasser T, Fusch C.
    J Pediatr; 2004 Jun; 144(6):753-8. PubMed ID: 15192622
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
    Allen DB, Carrel AL.
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
    [Abstract] [Full Text] [Related]

  • 13. Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome.
    Höybye C.
    Acta Paediatr; 2007 Mar; 96(3):410-3. PubMed ID: 17407467
    [Abstract] [Full Text] [Related]

  • 14. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.
    Carrel AL, Myers SE, Whitman BY, Allen DB.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, Ranke MB, Price DA, KIGS International Board.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.
    Höybye C, Hilding A, Marcus C, Thorén M.
    Growth Horm IGF Res; 2005 Dec; 15(6):411-5. PubMed ID: 16230042
    [Abstract] [Full Text] [Related]

  • 17. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome.
    Bizzarri C, Rigamonti AE, Giannone G, Berardinelli R, Cella SG, Cappa M, Müller EE.
    Horm Metab Res; 2004 Mar; 36(3):164-9. PubMed ID: 15057669
    [Abstract] [Full Text] [Related]

  • 18. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits.
    Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB.
    Am J Med Genet A; 2007 Mar 01; 143A(5):443-8. PubMed ID: 17103437
    [Abstract] [Full Text] [Related]

  • 19. The transition between the phenotypes of Prader-Willi syndrome during infancy and early childhood.
    Butler JV, Whittington JE, Holland AJ, McAllister CJ, Goldstone AP.
    Dev Med Child Neurol; 2010 Jun 01; 52(6):e88-93. PubMed ID: 20041936
    [Abstract] [Full Text] [Related]

  • 20. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
    Höybye C, Thorén M, Böhm B.
    J Intellect Disabil Res; 2005 Apr 01; 49(Pt 4):245-52. PubMed ID: 15816811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.